Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT05742789Phase 1Completed
Phase 1, randomised trial of propofol injection (veterinary), sevoflurane and isoflurane in mitral valve insufficiency (MR), aortic valve insufficiency (AI) and tricuspid valve insufficiency (TR) (3 arms), sponsored by Astana Medical University. Primary endpoints: Cardiac Troponin I at 48 hours and C-reactive protein at 5 days. Started Nov 2021; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT05742789.